Proactive Investors - Run By Investors For Investors

ICC International Cannabis closes C$45M private placement

The Vancouver cannabis company issued 42,187,500 units at a price of US$0.32 per unit
cannabis oil and plant
ICC International Cannabis's cultivation licenses already span four countries and three continents

ICC International Cannabis (CSE:WRLD.U) (OTCMKTS:WLDCF) said Friday it has successfully raised gross proceeds of C$45 million for general working capital after closing a private placement.

The Vancouver cannabis company issued 42,187,500 units at a price of US$0.32 per unit. Each unit is comprised of a share and one-half of one transferable share purchase warrant (each whole share purchase warrant being a warrant). Each warrant entitles its holder to purchase one additional share of ICC International Cannabis at a price of US$0.50 for a period of two years from the closing date.

READ: ICC International Cannabis on a quest to capture market share

Convertible debentures were also issued at a deemed value of US$0.38, which was the market price on March 6, 2019. The debentures bear interest at a rate of 10% per year from the date of issue, payable semi-annually in arrears on June 30 and December 31 of each year, beginning on June 30, 2019.

ICC International Cannabis is on a mission to become the first publicly listed, globally focused, vertically integrated, pure cannabis company and its cultivation licenses already span four countries and three continents.

ICC shares slipped less than C$0.01 to close at C$0.375 on Thursday.

Contact Ellen Kelleher at [email protected]

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full WRLD.U profile View Profile

ICC International Cannabis Corp. Timeline

Related Articles

Sydney Harbour Bridge
January 22 2019
A phase I study in Australia is evaluating a cannabis spray therapeutic in cancer patients.
cannabis flower
April 26 2019
The company's footprint continues to grow as it focuses on becoming a globally recognized house of brands with a broad portfolio of clients across North America
cannabis tablet
February 28 2019
The company fills a niche in the medicinal cannabis market, as it continues to push forward its suite of precision oral dose products
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use